CHRISTOPHER DAVIS: Open Payments
NPI 1922196724 · SPRINGFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,972 in 177 payments from 20 companies in 2025. Trend: 2023 $19,279 · 2024 $5,877 · 2025 $4,972
Food & beverage: $4,890Education: $81
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $861 |
| Axsome Therapeutics, Inc. | 24 | $579 |
| AstraZeneca Pharmaceuticals LP | 11 | $540 |
| Novo Nordisk Inc | 17 | $474 |
| Neurocrine BioSciences, Inc. | 10 | $335 |
| Teva Pharmaceuticals USA, Inc. | 9 | $308 |
| Vanda Pharmaceuticals Inc. | 6 | $304 |
| PFIZER INC. | 17 | $300 |
| Kowa Pharmaceuticals America, Inc. | 11 | $234 |
| Lilly USA, LLC | 5 | $208 |
Products named: VRAYLAR, Auvelity, INGREZZA, FANAPT, NURTEC ODT, BREZTRI, ZORYVE, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
